QurAlis
Catherine Forbes, CPA, currently holds the position of Controller at QurAlis since June 2022. Prior to that, Catherine worked as a Senior Accountant at Vor Biopharma from September 2020 to June 2022. With experience in advisory consulting at Deloitte and audit at Grant Thornton LLP, Catherine has built a strong foundation in accounting. Catherine earned a Master of Science in Accounting from Bentley University in 2018 after completing their Bachelor of Science in Accounting in 2017. Catherine graduated from Groton Dunstable Regional High School in 2013.
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.